Cargando…

Outgrowth of BT-474 human breast cancer cells in immune-deficient mice: a new in vivo model for hormone-dependent breast cancer.

The effect of co-inoculation of basement membrane matrix, Matrigel and two human breast cancer cell lines, BT-474 and SK-BR-3, was tested in immune-deficient mice. Both cell lines strongly overexpress c-ErbB-2 protein, whereas only BT-474 is reported to be oestrogen receptor positive. Co-inoculation...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Slooten, H. J., Bonsing, B. A., Hiller, A. J., Colbern, G. T., van Dierendonck, J. H., Cornelisse, C. J., Smith, H. S.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1995
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2034136/ https://www.ncbi.nlm.nih.gov/pubmed/7599056

Ejemplares similares

Development and Characterization of Nanoliposomal Hydroxyurea Against BT-474 Breast Cancer Cells
por: Akbari, Azam, et al.
Publicado: (2020)

Voltage-gated K(+) channels promote BT-474 breast cancer cell migration
por: Chow, Louis WC, et al.
Publicado: (2018)

Design and Characterization of Liposomal Methotrexate and Its Effect on BT-474 Breast Cancer Cell Line
por: Tavakoli Dastjerd, Niloufar, et al.
Publicado: (2021)

The inhibitory effect of trastuzumab on BT474 triple‑positive breast cancer cell viability is reversed by the combination of progesterone and estradiol
por: López-Méndez, José A., et al.
Publicado: (2023)

Protein O-glucosyltransferase 1 overexpression downregulates p16 in BT474 human breast cancer cells
por: JIN, GANG, et al.
Publicado: (2014)

Transcriptome profiling and proteomic validation reveals targets of the androgen receptor signaling in the BT-474 breast cancer cell line
por: Vasiliou, Stella K., et al.
Publicado: (2022)

Loss of Bcl-2 in invasive breast cancer is associated with high rates of cell death, but also with increased proliferative activity.
por: van Slooten, H. J., et al.
Publicado: (1998)

Chronic Morphine Treatment Attenuates Cell Growth of Human BT474 Breast Cancer Cells by Rearrangement of the ErbB Signalling Network
por: Weingaertner, Inka Regine, et al.
Publicado: (2013)

ONC201-Induced Mitochondrial Dysfunction, Senescence-like Phenotype, and Sensitization of Cultured BT474 Human Breast Cancer Cells to TRAIL
por: Mishukov, Artem, et al.
Publicado: (2022)

DNA ploidy of primary breast cancer and local recurrence after breast-conserving therapy.
por: Beerman, H., et al.
Publicado: (1991)

Correction: Chronic Morphine Treatment Attenuates Cell Growth of Human BT474 Breast Cancer Cells by Rearrangement of the ErbB Signalling Network
por: Weingaertner, Inka Regine, et al.
Publicado: (2016)

Correction: Chronic Morphine Treatment Attenuates Cell Growth of Human BT474 Breast Cancer Cells by Rearrangement of the ErbB Signalling Network
por: Weingaertner, Inka Regine, et al.
Publicado: (2015)

In Vitro Cytotoxicity of Trastuzumab (Tz) and Se-Trastuzumab (Se-Tz) against the Her/2 Breast Cancer Cell Lines JIMT-1 and BT-474
por: Bapat, Priyanka, et al.
Publicado: (2021)

Magnetic thermoablation stimuli alter BCL2 and FGF-R1 but not HSP70 expression profiles in BT474 breast tumors
por: Stapf, Marcus, et al.
Publicado: (2015)

Cardanol isolated from Thai Apis mellifera propolis induces cell cycle arrest and apoptosis of BT-474 breast cancer cells via p21 upregulation
por: Buahorm, Sureerat, et al.
Publicado: (2015)

In Vitro Evidence of Differential Immunoregulatory Response between MDA-MB-231 and BT-474 Breast Cancer Cells Induced by Bone Marrow-Derived Mesenchymal Stromal Cells Conditioned Medium
por: Arenas-Luna, Víctor M., et al.
Publicado: (2022)

Quercetin induces caspase-dependent extrinsic apoptosis through inhibition of signal transducer and activator of transcription 3 signaling in HER2-overexpressing BT-474 breast cancer cells
por: SEO, HYE-SOOK, et al.
Publicado: (2016)

Statins attenuate outgrowth of breast cancer metastases
por: Beckwitt, Colin H., et al.
Publicado: (2018)

Effect of hormone depletion on cell survival in the EMR-86 rat mammary carcinoma.
por: Wijsman, J. H., et al.
Publicado: (1996)

Expression of Bcl-2 in node-negative breast cancer is associated with various prognostic factors, but does not predict response to one course of perioperative chemotherapy.
por: van Slooten, H. J., et al.
Publicado: (1996)

Whole genome sequence analysis of BT-474 using complete Genomics’ standard and long fragment read technologies
por: Ciotlos, Serban, et al.
Publicado: (2016)

Induction of caspase-dependent extrinsic apoptosis by apigenin through inhibition of signal transducer and activator of transcription 3 (STAT3) signalling in HER2-overexpressing BT-474 breast cancer cells
por: Seo, Hye-Sook, et al.
Publicado: (2015)

The impact of standardized structured reporting of pathology reports for breast cancer care
por: Snoek, J.A.A., et al.
Publicado: (2022)

Human Blood Serum Inhibits Ductal Carcinoma Cells BT474 Growth and Modulates Effect of HER2 Inhibition
por: Kamashev, Dmitrii, et al.
Publicado: (2022)

Total Phenolic and Flavonoid Contents of Aqueous Extract of Stinging Nettle and In Vitro Antiproliferative Effect on Hela and BT-474 Cell Lines
por: Fattahi, Sadegh, et al.
Publicado: (2014)

Loss of heterozygosity on chromosome arm 16q in breast cancer: clinical, molecular and statistical approaches
por: Cleton-Jansen, A-M, et al.
Publicado: (2000)

Monocyte-derived macrophages promote breast cancer bone metastasis outgrowth
por: Ma, Ruo-Yu, et al.
Publicado: (2020)

Patients' preferences for adjuvant chemotherapy in early-stage breast cancer: is treatment worthwhile?
por: Jansen, S J T, et al.
Publicado: (2001)

Effectiveness of isolated liver perfusion with mitomycin C in the treatment of liver tumours of rat colorectal cancer.
por: Marinelli, A., et al.
Publicado: (1991)

Down-regulation of epithelial cadherin is required to initiate metastatic outgrowth of breast cancer
por: Wendt, Michael K., et al.
Publicado: (2011)

474 Productive and reproductive performance of Goat Breeds of Sindh.
por: Bilal, G, et al.
Publicado: (2018)

Profilin-1 deficiency leads to SMAD3 upregulation and impaired 3D outgrowth of breast cancer cells
por: Chakraborty, Souvik, et al.
Publicado: (2018)

Protein kinase C targeting of luminal (T-47D), luminal/HER2-positive (BT474), and triple negative (HCC1806) breast cancer cells in-vitro with AEB071 (Sotrastaurin) is efficient but mediated by subtype specific molecular effects
por: Albert, Veruschka, et al.
Publicado: (2022)

Long term storage in liquid nitrogen leads to only minor phenotypic and gene expression changes in the mammary carcinoma model cell line BT474
por: Fazekas, Judit, et al.
Publicado: (2017)

Evaluation of Mitotic Activity Index in Breast Cancer Using Whole Slide Digital Images
por: Al-Janabi, Shaimaa, et al.
Publicado: (2013)

FRI474 Panhypopituitarism And Central Hypothyroidism Presenting As Myoclonus And Hyperreflexia, An Unusual Presentation Likely Related To Thyrotropin-releasing Hormone
por: Nadeem, Ifrah, et al.
Publicado: (2023)

A prolactin-dependent, metastasising rat mammary carcinoma as a model for endocrine-related tumour dormancy.
por: Wijsman, J. H., et al.
Publicado: (1991)

Added Value of HER-2 Amplification Testing by Multiplex Ligation-Dependent Probe Amplification in Invasive Breast Cancer
por: Kuijpers, Chantal C. H. J., et al.
Publicado: (2013)

Screening for BRCA2 mutations in 81 Dutch breast–ovarian cancer families
por: Peelen, T, et al.
Publicado: (2000)

A family history of breast cancer will not predict female early onset breast cancer in a population-based setting
por: de Bock, Geertruida H, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_5i9jij0hljqsak4jdl76upc83d